2,993
Views
2
CrossRef citations to date
0
Altmetric
Research Article

FGFR2 modulates the Akt/Nrf2/ARE signaling pathway to improve angiotensin II-induced hypertension-related endothelial dysfunction

, &
Article: 2208777 | Received 06 Mar 2023, Accepted 25 Apr 2023, Published online: 08 May 2023

References

  • Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation. 2018;137(22):2344–10.
  • Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50. doi:10.1161/CIRCULATIONAHA.115.018912.
  • Wang S, Ding Z. Fibroblast growth factor receptors in breast cancer. Tumour Biol. 2017;39(5):1010428317698370. doi:10.1177/1010428317698370.
  • Wang B, Wu W, Xu K, Wu H. MicroRNA-223-3p is involved in fracture healing by regulating fibroblast growth factor receptor 2. Bioengineered. 2021;12(2):12040–48. doi:10.1080/21655979.2021.2002498.
  • Narla ST, Bushnell DS, Schaefer CM, Nouraie M, Tometich JT, Hand TW, Bates CM. Loss of fibroblast growth factor receptor 2 (FGFR2) leads to defective bladder urothelial regeneration after cyclophosphamide injury. Am J Pathol. 2021;191(4):631–51. doi:10.1016/j.ajpath.2020.12.011.
  • Chen X, Song D. LncRNA MEG3 participates in caerulein-induced inflammatory injury in human pancreatic cells via regulating miR-195-5p/FGFR2 axis and Inactivating NF-κB pathway. Inflammation. 2021;44(1):160–73. doi:10.1007/s10753-020-01318-6.
  • Xu Z, Zhu X, Wang M, Lu Y, Dai C. FGF/FGFR2 protects against tubular cell death and acute kidney injury involving Erk1/2 signaling activation. Kidney Dis (Basel). 2020;6(3):181–94. doi:10.1159/000505661.
  • Korkor MT, Meng FB, Xing SY, Zhang MC, Guo JR, Zhu XX, Zhu XX, Yang P. Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension. Int J Med Sci. 2011;8(2):168–79. doi:10.7150/ijms.8.168.
  • Zhang Z, Trautz B, Kračun D, Vogel F, Weitnauer M, Hochkogler K, Petry A, Görlach A. Stabilization of p22phox by hypoxia promotes pulmonary hypertension. Antioxid Redox Signal. 2019;30(1):56–73. doi:10.1089/ars.2017.7482.
  • Ding J, Yu M, Jiang J, Luo Y, Zhang Q, Wang S, Yang F, Wang A, Wang L, Zhuang M, et al. Angiotensin II decreases endothelial nitric oxide synthase phosphorylation via AT(1)R Nox/ROS/PP2A pathway. Front Physiol. 2020;11:566410.
  • Yu Q, Zhao J, Liu B. Bazedoxifene activates the angiotensin II-induced HUVEC hypertension model by targeting SIRT1. Exp Ther Med. 2022;23(2):120. doi:10.3892/etm.2021.11043.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–08. doi:10.1006/meth.2001.1262.
  • Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–18. doi:10.1016/S0140-6736(08)60655-8.
  • Gerage AM, Benedetti TRB, Ritti-Dias RM, Dos Santos ACO, de Souza BCC, Almeida FA, de Souza BCC. Effectiveness of a behavior change program on physical activity and eating habits in patients with hypertension: a randomized controlled trial. J Phys Act Health. 2017;14(12):943–52. doi:10.1123/jpah.2016-0268.
  • Ambrozova G, Fidlerova T, Verescakova H, Koudelka A, Rudolph TK, Woodcock SR, Freeman BA, Kubala L, Pekarova M. Nitro-oleic acid inhibits vascular endothelial inflammatory responses and the endothelial-mesenchymal transition. Biochim Biophys Acta. 2016;1860(11):2428–37. doi:10.1016/j.bbagen.2016.07.010.
  • Souza PS, Gonçalves ED, Pedroso GS, Farias HR, Junqueira SC, Marcon R, Tuon T, Cola M, Silveira PCL, Santos AR, et al. Physical exercise attenuates experimental autoimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption. Mol Neurobiol. 2017;54(6):4723–37. doi:10.1007/s12035-016-0014-0.
  • Vaillancourt M, Ruffenach G, Meloche J, Bonnet S. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Can J Cardiol. 2015;31(4):407–15. doi:10.1016/j.cjca.2014.10.023.
  • Reynolds JA, Rosenberg AZ, Smith CK, Sergeant JC, Rice GI, Briggs TA, Bruce IN, Kaplan MJ. Brief report: vitamin D deficiency is associated with endothelial dysfunction and increases type i interferon gene expression in a murine model of systemic lupus erythematosus. Arthritis Rheumatol. 2016;68(12):2929–35. doi:10.1002/art.39803.
  • Wesche J, Haglund K, Haugsten EM. Fibroblast growth factors and their receptors in cancer. Biochem J. 2011;437(2):199–213. doi:10.1042/BJ20101603.
  • Du X, Xie Y, Xian CJ, Chen L. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol. 2012;227(12):3731–43. doi:10.1002/jcp.24083.
  • Katoh M. Therapeutics targeting FGF signaling network in human diseases. Trends Pharmacol Sci. 2016;37(12):1081–96. doi:10.1016/j.tips.2016.10.003.
  • Allouche M, Bikfalvi A. The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Prog Growth Factor Res. 1995;6(1):35–48. doi:10.1016/0955-2235(95)00041-0.
  • Zhang Q, Chen L, Huang L, Cheng H, Wang L, Xu L, Hu D, He C, Fu C, Wei Q. CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction. Mol Med. 2022;28(1):145. doi:10.1186/s10020-022-00575-5.
  • Jiang Y, Wang Z, Chen X, Wang W, Wang X. ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress. Drug Des Devel Ther. 2018;12:4181–89. doi:10.2147/DDDT.S181312.
  • Tian M, Yang J, Yan X, Cao Y, Liu Y, Lei Y, Lv H. Knockdown of lncRNA TUG1 alleviates diabetic retinal vascular dysfunction through regulating miR-524-5p/FGFR2. Bioengineered. 2022;13(5):12661–72. doi:10.1080/21655979.2022.2075306.
  • Altaany Z, Moccia F, Munaron L, Mancardi D, Wang R. Hydrogen sulfide and endothelial dysfunction: relationship with nitric oxide. Curr Med Chem. 2014;21(32):3646–61. doi:10.2174/0929867321666140706142930.
  • Liu H, Chen T, Li N, Wang S, Bu P. Role of SIRT3 in Angiotensin II-induced human umbilical vein endothelial cells dysfunction. BMC Cardiovasc Disord. 2015;15(1):81. doi:10.1186/s12872-015-0075-4.
  • Cui J, Zhuang S, Qi S, Li L, Zhou J, Zhang W, Zhao Y, Qi N, Yin Y, Huang L. Hydrogen sulfide facilities production of nitric oxide via the Akt/endothelial nitric oxide synthases signaling pathway to protect human umbilical vein endothelial cells from injury by angiotensin II. Mol Med Rep. 2017;16(5):6255–61. doi:10.3892/mmr.2017.7328.
  • Zhao Y, Wang Q, Xie C, Cai Y, Chen X, Hou Y, He L, Li J, Yao M, Chen S, et al. Peptide ligands targeting FGF receptors promote recovery from dorsal root crush injury via AKT/mTOR signaling. Theranostics. 2021;11(20):10125–47. doi:10.7150/thno.62525.
  • Hu H, Hao L, Tang C, Zhu Y, Jiang Q, Yao J. Activation of KGFR-Akt-Mtor-Nrf2 signaling protects human retinal pigment epithelium cells from ultra-violet. Biochem Biophys Res Commun. 2018;495(3):2171–77. doi:10.1016/j.bbrc.2017.12.078.
  • Sato A, Nishioka S, Kiuchi M, Imada Y, Makino K, Nakagawa K, Tanaka R, Matsumura Y, Ohkita M. Grape Extract from Chardonnay Seeds Restores Deoxycorticosterone Acetate–Salt-Induced endothelial dysfunction and hypertension in rats. Biol Pharm Bull. 2020;43(1):59–67. doi:10.1248/bpb.b19-00540.
  • Chen YP, Sivalingam K, Shibu MA, Peramaiyan R, Day CH, Shen CY, Lai C-H, Chen R-J, Viswanadha VP, Chen Y-F, et al. Protective effect of Fisetin against angiotensin II-induced apoptosis by activation of IGF-IR-PI3K-Akt signaling in H9c2 cells and spontaneous hypertension rats. Phytomedicine. 2019;57:1–8.
  • Chen XY, Yang LP, Zheng YL, Li YX, Zhong DL, Jin RJ, Li J. Electroacupuncture attenuated phenotype transformation of vascular smooth muscle cells via PI3K/Akt and MAPK signaling pathways in spontaneous hypertensive rats. Chin J Integr Med. 2022;28(4):357–65. doi:10.1007/s11655-021-2883-y.
  • Ho JH, Baskaran R, Wang MF, Mohammedsaleh ZM, Yang HS, Balasubramanian B. Dipeptide if and exercise training attenuate hypertension in SHR rats by inhibiting fibrosis and hypertrophy and activating AMPKα1, SIRT1, and PGC1α. Int J Mol Sci. 2022;23(15):8167.
  • Lopes RA, Neves KB, Tostes RC, Montezano AC, Touyz RM. Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension. 2015;66(6):1240–50. doi:10.1161/HYPERTENSIONAHA.115.06163.
  • Ding Y, Chen M, Wang M, Wang M, Zhang T, Park J, Zhu Y, Guo C, Jia Y, Li Y, et al. Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in ischemic brain injury involves the Nrf2/HO-1 defense Pathway. Sci Rep. 2014;4(1):7002. doi:10.1038/srep07002.
  • Yao J, Long H, Zhao J, Zhong G, Li J. Nifedipine inhibits oxidative stress and ameliorates osteoarthritis by activating the nuclear factor erythroid-2-related factor 2 pathway. Life Sci. 2020;253:117292. doi:10.1016/j.lfs.2020.117292.
  • Meephat S, Prasatthong P, Potue P, Bunbupha S, Pakdeechote P, Maneesai P. Diosmetin ameliorates vascular dysfunction and remodeling by modulation of Nrf2/HO-1 and p-JNK/p-NF-κB expression in hypertensive rats. Antioxid (Basel). 2021;10(9):1487. doi:10.3390/antiox10091487.